Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Chemopreventive Regimens to Prevent Malaria and Improve Birth Outcomes in Uganda

NCT04336189 is registered in ClinicalTrials.gov with Grant Dorsey, M.D, Ph.D. as lead sponsor.

NCT NCT04336189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04336189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Chemopreventive Regimens to Prevent Malaria and Improve Birth Outcomes in Uganda
Lead sponsor
Grant Dorsey, M.D, Ph.D.
Phase
Phase 3
Overall status
Completed
Start date
December 28, 2020
Completion date
July 28, 2024
Enrollment
2,757 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria